PreveCeutical Medical Inc.

PRVCF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$59$1$6$16
Short-Term Investments$0$0$0$0
Receivables$27$5$19$55
Inventory$0$0$0$0
Other Curr. Assets$31$57$39$12
Total Curr. Assets$117$64$63$83
Property Plant & Equip (Net)$2$1$1$2
Goodwill$0$0$0$0
Intangibles$106$117$125$76
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$109$118$126$79
Other Assets$0$0$0$0
Total Assets$226$182$189$161
Liabilities
Payables$911$579$371$383
Short-Term Debt$4,398$3,894$3,292$1,253
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,491$1,487$1,161$953
Total Curr. Liab.$6,800$5,960$4,824$2,589
LT Debt$63$0$0$1,676
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$63$0$0$1,676
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$6,863$5,960$4,824$4,265
Equity
Pref Stock$0$0$0$0
Common Stock$19,594$19,308$19,308$18,562
Retained Earnings-$29,560-$28,409-$27,260-$28,526
AOCI$2,012$2,009$3,316$1,385
Other Equity$1,317$1,313$0$4,475
Total Equity-$6,637-$5,778-$4,635-$4,104
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$226$182$189$161
Net Debt$4,401$3,893$3,286$2,913